New drug to stop 'Ozempic butt' muscle loss side effect of obesity jabs
A third of the weight loss from obesity jabs can come from muscle, say experts.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"The findings were promising but should be viewed as 'encouraging early evidence' rather than definitive proof of clinical benefit."
— Dr Marie Spreckley , Academic
"The treatment might not be suitable for everyone on GLP-1 drugs, but might help some who are losing muscle mass particularly fast."
— Dr Brendan Gabriel , Academic
"The findings were promising but should be viewed as 'encouraging early evidence' rather than definitive proof of clinical benefit."
— Dr Marie Spreckley , Academic
Key People
Tags
All Coverage
A third of the weight loss from obesity jabs can come from muscle, say experts.
Researchers are developing a new medication to combat muscle loss associated with popular weight loss injections, as up to one-third of weight reduction from obesity jabs comes from muscle tissue.
A new muscle growth drug called apitegromab significantly reduced lean tissue loss for patients using GLP-1 slimming jabs during a 24-week clinical trial, allowing patients to retain 55% more muscle mass compared to those receiving a placebo.
A new drug called apitegromab could help people on obesity jabs avoid unwanted muscle decline that’s been linked to flat bums or “Ozempic butt”, according to research in the Nature Medicine journal.
Researchers are developing a new medication to combat muscle loss associated with popular weight loss injections. Experts say up to one-third of weight reduction from obesity jabs comes from muscle tissue.
A new muscle growth drug called apitegromab significantly reduced lean tissue loss for patients using GLP-1 slimming jabs during a 24-week clinical trial published in Nature Medicine on June 8, 2026.
A new drug called apitegromab could help people on obesity jabs avoid unwanted muscle decline that's been linked to flat bums or 'Ozempic butt', according to research in Nature Medicine journal.
A new drug called apitegromab could help people on obesity jabs avoid unwanted muscle decline that's been linked to flat bums or 'Ozempic butt', according to research in Nature Medicine journal.
Similar Stories
Related coverage based on topic and tags
'What terminal cancer has taught me about life'
A Gloucestershire man with terminal cancer shares the life lessons he wishes he'd learned sooner.
October 10, 2026 at 06:16 AMWhat happens when you don't know your family medical history?
People who have been adopted or in care sometimes struggle to access family medical history which would be crucial to their own health.
October 10, 2026 at 05:45 AMQuestions remain over Ebola patient who travelled across three nations undetected
Fresh details reveal how the 40-year-old businessman flew and crossed regional borders while seriously ill.
October 10, 2026 at 12:00 AMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMUS measles cases rise to 4,080, CDC says - Reuters
US measles cases rise to 4,080, CDC says Reuters
October 9, 2026 at 05:45 PMPrize-winning image which sparked backlash was AI-generated, Nikon rules
The camera-maker says it is now re-evaluating the rules and procedures of its Small World in Motion contest.
October 9, 2026 at 03:32 PM